NEUROGENE INC (NGNE:NASDAQ)
$27.02 -0.08 (-0.2952%)
Analysed NEUROGENE INC (NGNE:NASDAQ) News Sources
Neurogene to Participate in Stifel 2026 Virtual CNS Forum
11-03-2026
yahoo.com
Neurogene CEO Details NGN-401 Rett Trial, FDA Alignment, and Key 2026 Catalysts at Conference
21-03-2026
marketbeat.com
Neurogene Reports Full Year 2025 Financial Results and Highlights Recent Updates
24-03-2026
yahoo.com
Neurogene: Q4 Earnings Snapshot
24-03-2026
yahoo.com
Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors
20-04-2026
yahoo.com
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
28-04-2026
yahoo.com
We Think Neurogene (NASDAQ:NGNE) Can Afford To Drive Business Growth
05-05-2026
yahoo.com
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06-05-2026
yahoo.com
Neurogene Highlights Data at ASGCT Meeting Supporting Therapeutic Rationale for ICV Delivery Method in CNS-targeted Gene Therapy
12-05-2026
yahoo.com
Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates
12-05-2026
yahoo.com
What is the current price of NEUROGENE INC (NGNE:NASDAQ)?
The current price of NEUROGENE INC (NGNE:NASDAQ) is $27.02.
NEUROGENE INC (NGNE:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROGENE INC (NGNE:NASDAQ) since the previous trading day is $-0.08.
NEUROGENE INC (NGNE:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROGENE INC (NGNE:NASDAQ) since the previous trading day is -0.2952%.
What is the most recent average sentiment score for NEUROGENE INC (NGNE:NASDAQ)?
The most recent average sentiment score for NEUROGENE INC (NGNE:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for NEUROGENE INC (NGNE:NASDAQ)?
The most recent sentiment for NEUROGENE INC (NGNE:NASDAQ) is .
SEC-8K** Filing Available For NEUROGENE INC (NGNE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.